Email Updates

You are here

Home

15 OCTOBER 2021 VOLUME 23 ISSUE 41

Media Coverage

  • Initiatives To Accelerate the Long and Difficult Search for an HIV Vaccine

    It is paradoxical that the speed in obtaining vaccines against COVID-19 is due, in large part, to the enormous advantage provided by research on HIV and its key technologies and that, however, we still continue without an immunization against the virus AIDS. To move forward, we need increased funding and consistent commitment from the industry.

    October 14, 2021
    HIV Vaccine
    Agencia SINC

  • Nigeria Committed to Global Drive on Eliminating Mother-to-child HIV Transmission, Says FG

    The Federal Government has expressed commitment to global drive to eliminate mother-to-child transmission of HIV and ensure zero new infections by 2025. This came as statistics show that only 27 percent of HIV positive pregnant women are able to access Prevention of Mother-To-Child Transmission (PMTCT) services, while 63 percent are unable to do so. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), Nigeria contributes 22,000 new infections among children every year.

    October 14, 2021
    Treatment
    The Guardian

  • An HIV Cure Won’t Matter If We Don’t Fix Our Infrastructure

    Within the United States, the rollout of COVID-19 vaccines has taught us that even if a vaccine for HIV was created tomorrow, it would not make much difference for Black communities. This is, in large part, because Black people, who remain disproportionately harmed by both viruses, continue to be deprived of access to quality health care.

    October 13, 2021
    Treatment
    TheBody

  • Condoms and Other Sex Aids To Be Allowed into North's Prisons

    Condoms and other sexual aids are set to be allowed into the north’s prisons for the first time. Officials have confirmed that inmates will be given access to a range of items after a bisexual prisoner, who has been granted anonymity, threatened to take legal action earlier this year. The items include condoms, dental dams and water-based lubricants.

    October 13, 2021
    Male and Female Condoms
    The Irish News

  • What About Those Mysterious RNA Molecules Created by HIV?

    When HIV replicates in human cells, it generates circular RNA molecules, the function and precise composition of which remain a mystery. Florida scientist Massimo Caputi, PhD, who discovered these novel molecules, aims to figure out whether they might possibly lead to new HIV treatments.

    October 13, 2021
    HIV Vaccine
    POZ

  • John Nkengasong, Ph.D., Is Biden’s Pick to Fill the Long-Empty Role of US Global AIDS Czar

    In June, we reported that PEPFAR, the $7 billion US global-AIDS relief program started by President George W. Bush in 2003, had been leaderless for more than a year. This left global AIDS advocates worried that the program was losing momentum and focus, especially amid the new global pandemic of COVID-19.

    October 12, 2021
    General
    TheBody

  • IDWeek 2021: The Future of ART Is Long Acting—A Look at What’s Here and What’s Ahead

    “I think long-acting HIV therapy really is the future.” Those were the words of David Wohl, MD, a professor of medicine at the University of North Carolina, Chapel Hill, as he began his presentation on long-acting agents to treat HIV at the 2021 virtual IDWeek conference.... With the advent of single-tablet regimens (over a dozen at this point), Wohl noted, there is little room for improvement in pill burden for oral antiretroviral therapy (ART) regimens. Instead, we are likely to see more and more long-acting regimens coming into widespread use, first as injectables—either intramuscular or subcutaneous—and soon enough in other dosing forms, including implants and patches.

    October 12, 2021
    Treatment
    TheBodyPro

  • Low HIV PrEP Awareness and Referrals among High-Risk Hispanic Populations

    Hispanic or Latino persons are disproportionately affected by HIV. As of 2019, Hispanic persons were 18 percent of the US population, but represented 29 percent of new HIV diagnoses. Pre-exposure prophylaxis (PrEP) is an effective strategy for preventing HIV infection among high-risk groups. To gauge if Hispanic persons were aware of and being referred for PrEP, the CDC conducted an analysis of the 2019 National HIV Prevention Program Monitoring and Evaluation HIV testing data.

    October 11, 2021
    PrEP
    Contagion Live

  • The Over-criminalisation of HIV Transmission Does More Harm than Good

    It is a well-known fact that the prevalence of HIV in South Africa is among the highest in the world. A lesser-known fact is that people living with HIV can be charged with attempted murder for exposing others to or spreading HIV, despite the fact that living with HIV is no longer a “death sentence” due to the availability of antiretroviral therapy.

    October 10, 2021
    General
    Daily Maverick

  • What the Malaria Vaccine Means for Africa

    Like many who work in public health, especially in sub-Saharan Africa, I’ve been waiting my whole career for a malaria vaccine. And even longer than that: I suffered from severe malaria when I was 10.

    October 10, 2021
    General
    New York Times

  • How Biodiversity Loss Is Jeopardising The Drugs of the Future

    What will biodiversity loss mean for drug discovery? Traditionally used as a painkiller for headaches, snowdrops are now known to slow the onset of dementia. In the 1950s, a natural alkaloid called galantamine was extracted from the bulbs. Today, a synthesised version of this is used to treat Alzheimer’s disease and scientists are investigating further to see if snowdrops might also be effective in the treatment of HIV.

    October 9, 2021
    General
    The Guardian

  • Free HIV Test Vending Machines Launch in Brighton and Hove

    A set of free sexual health and HIV test vending machines have officially launched. The machines launched at five sites across Brighton and Hove on Friday, October 8. The vending machines offer sexual health self-sampling kits and HIV self-tests free of charge.

    October 9, 2021
    General
    The Argus

  • Action Needed To Address Cancer Risk among Young People with HIV

    Researchers in South Africa have analysed 10-year’s worth of medical records to shed light on cancer risk among young people with HIV. Although cancer is rare for young people, what limited evidence exists suggests that young people with HIV are more at risk than their peers. To help close the evidence gap, the South African HIV Cancer Match (SAM) study linked national HIV and cancer data from adolescents and young people (ages 15–24) collected between 2004 and 2014. It is one of the largest studies to examine cancer among young people with HIV to date.

    October 7, 2021
    General
    Avert

  • Women Less Likely to Win Major Research Awards

    Women’s share of international prizes rewarding research excellence is increasing, but still lags behind the proportion of professorial positions held by women, according to an analysis of 141 top science prizes awarded over the past two decades.

    September 13, 2021
    General
    Nature

Published Research

Announcements